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ABSTRACT 
Introduction: In peritoneal dialysis (PD), convective and diffusive transport and 
osmosis are created through the peritoneal membrane in order to replace a faulty 
renal function. The transport across the membrane involves a rich microvascular 
network with paramount importance in the exchange process and rate. Aquaporins 
(AQP) are protein channels present in the capillaries walls, which facilitate the 
passive flux of water in presence of osmotic pressure, corresponding to the 
ultrasmall pore hypothesized by Rippe et al. responsible for the free water 
transport (FWT). The importance of aquaporins is undeniable, but the exact role of 
aquaporins in the pathophysiology of peritoneal dialysis and underlying processes 
such as ultrafiltration failure, inflammation, fibrosis and neoangiogenesis remains 
unclear. 
Objectives: The aim of this work is to review the structure and functioning of 
aquaporins, their contribution in peritoneal physiology and potential as a 
pharmacological target.  
Discussion: the discovery of aquaporins represented a breakthrough in human 
physiology, particularly in peritoneal dialysis. They represent not only a part of the 
explanation of water transport but an entirely new piece in the puzzling peritoneal 
transport and dysfunction, where their relation with other key processes and 
players such as a mesothelial cells, extracellular matrix and capillary network is not 
clear and deserves special attention. With a substantial share of knowledge of the 
channel provided by in silico models, KO null mice and in vitro cell culture, the 
clinical monitorization of aquaporin function will lead to a more integrated and 
accurate estimative of the aquaporin importance in prognosis and outcome of 
patients in peritoneal dialysis. 
The modulation of aquaporins is possible but the compounds discovered so far, 
(transition metals) are too toxic for a safe use in clinical practice. The recent 
advance of in vitro monitoring of cell swelling provided the screening of compound 
libraries in a systematic way, and discovery of new molecules with promising 
results. The discovery of an aquaporin agonist and the possibility of modulation 
therapy could mean a significant shift in peritoneal dialysis, with the expectation of 
an even more efficient and prolonged technique. 
 
Conclusions: Peritoneal dialysis represents an attractive form of renal 
replacement. More biocompatible peritoneal dialysis solutions and remodeling 
blockers are needed to a long-lasting technique. Aquaporins represent a major role 
in the pathophysiology of the peritoneal barrier, as the ultrasmall pore and in the 
pathological changes observed during peritoneal dialysis since it’s involved in 
various processes like cell migration, angiogenesis and inflammation. Their study 
will bring further knowledge relevant not only to peritoneal dialysis, but to human 
physiology and cell biology. 
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RESUMO EXTENDIDO 
Desde a sua formulação enquanto hipótese teórica nos anos 80 até à 
demonstração da sua existência enquanto canal condutor de água, as 
aquaporinas têm sido alvo de investigação intensa que contribuiu para a 
evolução do papel primordialmente atribuído de canal passivo de fluxo de água. 
As aquaporinas são uma família de proteínas transmembranares que se 
encontram divididas em 3 grupos consoante as suas capacidades de conduzir 
solutos, água e glicerol: aquaporinas ortodoxas, aquagliceroporinas e 
aquaporinas não ortodoxas. Nos mamíferos são reconhecidas 13 isoformas 
com diferenças a nível funcional e filogenéticas condicionadas por uma 
diferente codificação genética e ultra-estrutura. 
Estruturalmente são tetrâmeros compostos por quatro monómeros. Cada 
monómero é formado por seis segmentos helicais e respectivas ansas de 
comprimento variável. A ligação entre hélices dá origem a uma estrutura 
semelhante a uma ampulheta com o motivo NPA no centro. Esta ligação é 
estabilizada pela tetramerização e empacotamento das hélices. A orientação 
das hélices e dos domínios extracelulares condiciona a conformação final da 
aquaporina e a sua selectividade à água. A alteração destes domínios leva a 
alterações drásticas da capacidade de condução podendo mesmo resultar num 
poro não funcionante. Baseado neste facto, uma das metodologias de estudo 
de aquaporinas consiste na alteração de resíduos por mutagénese e 
observação das alterações na capacidade de condução, permitindo estabelecer 
a importância de determinados resíduos e explicar as diferenças entre AQPs. A 
alteração estrutural por factores extrínsecos é denominada gating e tem como 
principio a existência de diferentes estados conformacionais. 
As características do canal, nomeadamente a sua geometria e existência de 
dois locais de constrição (ar/R e NPA) tornam o canal selectivo para água: pelo 
diâmetro do poro e pela criação de uma barreira energética. 
Relativamente às isoformas das aquaporinas e aquagliceroporinas, a maior 
diferença reside no diâmetro do poro, 2.8A e 3.4A, respectivamente. 
A regulação destes canais ainda não se encontra completamente 
esclarecida, no entanto os principais mecanismos propostos são transcrição, 
transporte membranar e gating. 
  
 
O último já comprovado em AQP vegetais mas ainda discutido em AQPs 
humanas. 
Muito do conhecimento do transporte membranar deriva do modelo mais 
conhecido de controlo da AQP2 no rim. Neste a acção da vasopressina e 
subsequente activação da proteína cinase A, leva à migração e fusão de 
vesículas com AQP2 para a membrana. Recentemente, foi proposto um 
mecanismo de translocação para AQP1 em resposta a meios hipotónicos, que 
cursa com elevação do cálcio intracelular e fosforilação da AQP1 para a 
membrana em 30s. 
 
A presença e distribuição destes canais varia conforme o órgão, porém o seu 
papel no endotélio e epitélio já era esperado, contudo o mesmo não se poderá 
dizer das funções recentemente atribuídas na migração e transmissão de 
impulso nervoso. No epitélio, contribui para o transporte de fluidos de diferentes 
modos: fluxo quase isosmolar e ampliação de fluxo no transporte activo. No rim 
é importante no transporte de água e na permeabilidade de determinados 
segmentos do nefrónio. A ausência de AQP1 em ratos AQP1 nulos, resulta 
numa disfunção urinária grave, com poliúria e incapacidade de concentrar 
urina. 
No cérebro, a AQP4 funciona como um canal bidireccional e em ratos AQP4 
nulos foram observadas taxas de sobrevivência díspares em resposta a 
diferentes tipos de edemas induzidos. 
Outros estudos experimentais demonstraram uma participação inesperada 
das aquaporinas noutros fenómenos fisiológicos: migração celular, proliferação 
celular, metabolismo de lípidos e hidratação da pele. 
As Aquaporinopatias são doenças caracterizadas por uma disfunção de 
aquaporinas , os mecanismos até agora conhecidos são: mutações com perda 
de função e resposta imune contra os epitopos extracelulares da APQ4. 
Mutações com perda de função são extremamente raras mas foram registados 
casos de diabetes insípida nefrogénica (AQP2) e cataratas congénitas (AQP0) 
atribuíveis à perda de aquaporinas. Por outro lado, a neuromielite óptica é um 
distúrbio auto-imune com afecção de aquaporinas por dano mediado por 
anticorpos específicos. 
  
 
A associação entre polimorfismo de aquaporinas e patologias especificas 
ainda não se encontra descrito. 
A diálise peritoneal apresenta-se como uma técnica de substituição renal 
com uma sobrevivência equivalente a hemodiálise, que pela sua relativa 
simplicidade, menores custos e melhor qualidade de vida dos pacientes é 
considerada como vantajosa. 
A diálise peritoneal consiste assim na utilização da cavidade peritioneal e 
respectiva membrana peritoneal como interface de transporte entre solução de 
diálise e sangue, com extracção de água circulante e toxinas. Na práctica 
consiste na instalação de dialisado, um período de repouso e uma drenagem 
no fim do procedimento. 
O transporte de solutos e água é obtido pela criação de gradientes osmóticos 
e de concentração entre sangue e dialisado, cuja composição inclui 
concentrações fisiológicas de iões (sódio, cloro, cálcio e magnésio), um agente 
osmótico (comummente glucose) e um composto tampão para estabilizar o pH 
da solução. Desta forma a água é extraída por osmose, pequenos solutos por 
difusão e macromoléculas por convecção. 
O conceito de peritoneu, enquanto membrana e barreira de transporte é 
extremamente relevante para a diálise peritoneal e para os processos 
fisiopatológicos subjacentes. 
O conceito anatómico de peritoneu difere do conceito de barreira de 
transporte em diálise peritoneal: nesta última para além do mesotélio e 
respectiva membrana basal, o interstício e microvasculatura são incluídos. Daí 
que a área total de peritoneu não corresponda a área que efectivamente 
participa nas trocas, uma vez que esta se encontra condicionada por outros 
factores. 
A microvasculatura, formada por capilares contínuos e com capacidade auto-
reguladora, é considerada a maior barreira de trocas, comportando-se com 
uma estrutura heteroporosa composta por poros de 3 tamanhos diferentes. 
Esta característica confere-lhe selectividade e influencia as taxas de transporte 
observadas. Os poros são divididos em grandes, pequenos e ultrapequenos. 
A ultrafiltração, que corresponde a quantidade de água livre de solutos que 
atravessa a membrana, é um marcador preditivo de sobrevivência em doentes 
submetidos a diálise peritoneal. Segundo o modelo de Rippe, os ultrapequenos 
  
 
poros são responsáveis pela ultrafiltração e correspondem morfologicamente 
as aquaporinas presentes no endotélio vascular. 
Este achado explica o fenómeno observado na prática clinica de dissolução 
do sódio na primeira hora de diálise que foi atribuído à ultrafiltração pelas 
aquaporinas. A correspondência morfológica foi comprovada pela inibição de 
aquaporinas e uma perda de ultrafiltração sobreponível ao modelo teórico. 
Na prática clinica, a quantificação de ultrafiltração atribuível às aquaporinas 
permite uma caracterização mais detalhada do perfil de transporte do doente. 
A perda de função peritoneal é observada em doentes com PD de longa 
duração e deriva da utilização não fisiológica do peritoneu. O remodelamento 
peritoneal corresponde as alterações deletérias que são observadas em 
respostas a uma variedade de insultos, agudos e crónicos. Estas alterações 
traduzem-se em mudanças no microambiente celular com a sinalização celular 
predominantemente orientada para inflamação, fibrose e recrutamento de 
células.  
Vários factores contribuem para este estado pró-inflamatório: a composição 
da solução da diálise, peritonite, o cateter e a uremia.  
A glucose usada como agente osmótico nas soluções de diálise é 
considerada um dos factores determinantes no processo patológico, uma vez 
que os seus produtos de degradação vão induzir uma resposta inflamatória por 
parte das células mesoteliais com libertação de factores de crescimento, 
citocinas e recrutamento de células. 
Apesar de não constituir um obstáculo ao transporte de água e solutos, o 
mesotélio desempenha um papel fundamental na resposta a estímulos como a 
diálise e peritonite. É capaz de sofrer transdiferenciação, e adquirir um perfil 
pró-fibrótico (miofibroblasto), bem como responder a estímulos de células 
vizinhas. A integridade do mesotélio reflecte o grau de dano a que o peritoneu 
foi submetido.  
Todas estas alterações são sustentadas pela libertação de mediadores, 
factores de crescimento e citocinas. Destes destaca-se o TFG-β por induzir as 
alterações descritas no mesotélio e pela sua produção pelo próprio mesotélio 
induzir o remodelamento nas estruturas vizinhas. Contudo, são múltiplos os 
eixos de sinalização presentes no remodelamento peritoneal, sendo que 
actualmente se investiga a importância de polimorfismos em determinados 
  
 
eixos como o RAS e variações de receptores, de maneira a explicar as 
diferentes alterações observadas nos doentes submetidos a DP e os diferentes 
perfis de transporte. 
Deste modo, à luz do conhecimento actual que as aquaporinas estão 
envolvidas não só no processo ultrafiltrativo mas também em fenómenos como 
angiogenese e migração celular, as aquaporinas podem ter uma participação 
no processo fisiopatológico do peritoneu para além da sua função na 
ultrafiltração de água. Presumivelmente, os mesmos mecanismos lesionais 
envolvidos no remodelamento podem afectar as aquaporinas, tendo se 
proposto possíveis mecanismos e alvos.  
Do mesmo modo, a influência das próprias aquaporinas na biologia da célula 
não é completamente clara, uma vez que os mecanismos de regulação não 
são completamente conhecidos. 
Deste modo as aquaporinas apresentam-se como um atraente alvo 
terapêutico, contudo até a data não foi descoberto nenhum antagonista com 
capacidade de ser utilizado in vivo. Por sua vez, os agonistas constituem uma 
hipótese teórica, porém nenhum composto com acção directa sobre o canal. 
De salientar a transcrição aumentada obtida por Arteaga et al, que através de 
glucocorticóides obteve um maior numero de AQPs na membrana e 
subsequente aumento da taxa de UF em doentes seleccionados. 
Os mais recentes avanços em termos de técnicas de screening de fármacos 
e simulação computacional irão acelerar o processo de descoberta de 
potenciais fármacos. 
Novas linhas de investigação são necessárias para clarificar a real 
importância das aquaporinas. 
As aquaporinas representam assim o ultrapequeno poro previsto por Rippe 
mas também uma nova janela sobre o processo fisiopatologico da barreira 
peritoneal e da própria fisiologia humana. 
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ABBREVIATIONS AND ACRONYMS 
 
ACEi – angiotensin conversion enzyme inhibitor 
 
AGE – advanced glycosylation endproducts 
 
APD- automated peritoneal dialysis 
 
AQP-  aquaporin 
 
ARB – angiotensin receptor blocker 
 
CAPD – continuous ambulatory peritoneal dialysis 
 
CHIP28 – channel forming integral protein 28 
 
ESRD - end-stage renal disease 
 
FWT - free water transport 
 
GDPs – glucose degradation products 
 
GFR- glomerular filtration rate 
 
MC- mesothelial cells 
 
NOS- Nitrous oxide synthase 
 
NPA- sequence of 3 aminoacides (Asn-Pro-Ala ) highly conserved in 
aquaporins 
 
PD - peritoneal dialysis 
 
ROS- reactive oxygen species 
 
RAS- renin angiotensin system 
 
SD – standard deviation 
 
TEA - tetraetylammonium 
 
UF - ultrafiltration 
 
UFF- ultrafiltration failure 
 
VEGF- vascular endothelial growth factor 
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I – AQUAPORINS 
 Discovery and Definition 
 Structure of Aquaporins 
 Water Permeation and Small Solute Transport 
 Regulation of Aquaporins 
 
Since their formulation as theoretical hypothesis in the 80´s1 until the 
demonstration in 1992 of CHIP28 as an water channel by Preston et al2., the 
aquaporins are a scientific subject of intense research and the simplistic view of 
a passive water channel has evolved and today they are linked to innumerous 
physiological processes from embryogenesis to cancer biology. 
Aquaporins are an ancestral family of transmembranar proteins (channels) 
divided until now in three groups3, by their ability to facilitate the passage of 
water, small solutes and glycerol in: orthodox aquaporins, aquaglyceroporins 
and unorthodox aquaporins. Their presence and distribution seems to be 
universal, being present in all living beings, animals and plants.4  When isolated 
from the rest of the other aquaporin subfamilies, the mammalian AQP’s are a 
group composed of 13 different members with functional and phylogenetic 
differences conditioned by their genetic coding and ultra-structure. 
Structurally they are a tetramers composed of four monomers in which six 
helical segments and respective loops of variable length connect with each 
other to form the basic subunit, the monomer5 (Fig.1-A). The connection 
between helices gives rise to the AQP fold and the NPA motif that is localized in 
the center of the fold, the stability of this fold is provided by the packing of 
helices and by tetramerization (Fig.1-B). 
The orientation of the helices and the exposed extracellular domain 
condition the conformation6 of the channel and his selectivity to water. The 
channel can therefore by divided in extracellular and cytoplasmatic vestibules 
and pore. Each monomer functions as an independent pore, so that one 
aquaporin is actually constituted by four pores.  
The channel characteristics, with a diameter of the vestibule of 2.8A and two 
constriction zones7 (ar/R and NPA motif), make the channel selective to water 
by size and by creation of an energetic barrier by the dipole moments of helices 
B and E which impedes the penetration of protons. The energetic cost of 
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transporting water along the membrane is compensated by the interactions of 
water with “walls” of the pore, lowering the energy of the system8. 
The geometry and structure of the pore are major factors in the function of 
aquaporins9, since changes in critical residues at pore entrance and channel 
itself alter drastically the pore conductance and selectivity, resulting even in 
total obstruction of the pore and as result a non-functioning channel. This fact 
has been used as basis to experimental protocols10 that induce mutations in 
specific sites to test the relevance of a given residue, being particularly useful in 
explaining differences in permeation between different AQP’s. Changes in the 
structure induced by external factors are termed gating, and it gives rise to a 
different conformational status and permeability of an AQP11. 
Based on these differences between isoforms of aquaporins they are, as 
mentioned before, grouped in aquaporins that exclusively permeate water and 
aquaglyceroporins, permeable to water, glycerol and urea (AQP 3, 7, 9 and 10) 
based on the striking difference between pore diameters 2.8A vs 3.4A, 
respectively. AQP9 is capable of transporting amino acids, small polar solutes 
and even sugars. Other small molecules and gases such as CO2, NH3, NO and 
H202 are small enough to pass the pore, but due to the intrinsic high 
permeability of the phospholipid membrane to gases the biological impact is 
thought to be minimal. Presently is in under intense discussion the possibility of 
AQP1 be a multifunctional channel in vivo, this hypothesis is gaining further 
evidence and is based on the ability of the central pore to conduct cations under 
special conditions12-14. It physiological meaning is still obscure with proposed 
roles in signal transduction, mechanical compliance to pressure, organelle 
volume regulation and cell volume in migration. 
The regulation of AQP’s is still a debated question, where the gating, 
trafficking and transcription of AQP’s pose as the main mechanisms for 
controlling cell water homeostasis15. Since AQP1 is constitutionally expressed 
in the membrane and the abundance of it (via transcription and expression) 
controls the tissue/cell response to the environment, this axis of control doesn’t 
provide the explanation for rapid adaption to changes of the extracellular 
environment. The gating mechanism could partially explain this by coupling of 
water transport to cell signaling and metabolism. Gating is proven in plant 
 13 
 
AQP16,17, but not widely accepted in human AQP’s and its potential meaning in 
such a dynamic system is difficult to predict15. 
 AQP2 trafficking induced by vasopressin in the kidney presents as one of 
most studied models18,19 and could provide clues to the key mechanisms in 
AQP1 control. Here the AQP2 and AQP3, present in the collecting duct are 
responsible for the permeability of this segment by responding to a rise in 
vasopressin concentrations which binds to the V2 receptors in the basolateral 
membrane which cause a cascade of reactions with activation of protein kinase 
A (PKA) and the migration and fuse of AQP2 vesicles to the membrane, 
augmenting permeability to water. Long term regulation is achieved when 
circulating vasopressin are increased for a long period of hours resulting in 
increased transcription. Recently, Conner et al20,21 demonstrated that rapid 
translocation of AQP1 in response to a hypotonic stimulus induced a 
intracellular calcium elevation, activation of calmodulin and phosphorylation of 
AQP1 with effective translocation within 30s. This could represent the missing 
link between rapid volume changes and AQP status. 
 
 
14 
 
II- ROLE OF AQUAPORINS IN HUMAN PHYSIOLOGY 
  
 Presence and Distribution in the Human Body 
 Function and Relevance in Different Organs 
 Non Predicted Functions of Aquaporins 
 Emergence of a new disfunction: Aquaporinopathies 
 Diagnosis of AQP disfunction 
 
The presence and distribution of AQP’s varies according to the organ, but 
there is an universal distribution in human epithelia and endothelia, fulfilling the 
anticipated role in water transport and gland fluid secretion; other roles like cell 
migration and neural signaling were proposed after observation of impairment in 
KO-mice. 
In epithelial cells the exchange of water across barriers was expected, and 
can be performed in two different ways22: active near-isosmolar fluid transport, 
as in the kidney proximal tube absorption and acinar epithelium secretion of 
salivary glands; and an active fluid transport across epithelia in which the AQP 
amplifies the fluid transport caused by an osmotic gradient actively generated 
by solute transport. AQP1 has a critical role in transepithelial water transport in 
presence of a significant osmotic gradient as demonstrated by the AQP1 null 
mices which present severe polyuria and impaired urinary concentration. In fact 
AQP1 function in the thin ascending limb of Henle and collecting duct maintains 
the countercurrent multiplication mechanism and exchange resulting in a 
hypotonic medulla and diminished reabsorption by the proximal tube. In rare, 
AQP2 mutation in humans the resulting disease is a nephrogenic diabetes 
insipidus, with leading symptoms of polyuria and lack of urine concentration 
ability.  
In the brain, AQP4 presents itself as bidirectional water channel facilitating 
fluid transport according to the nature of the stimuli as demonstrated by 
Verkman et al in AQP4 null mices with clearly different  outcomes: improved 
survival of null mices in cytotoxic edema23, with a flow driven by osmotic forces 
through an intact blood-brain barrier (impedance of flow into the brain) and 
poorer survival in vasogenic edema24, where a disrupted blood-brain barrier 
leaks and drags water with it, which has little escape route since AQP4 is 
disabled resulting in greater brain edema. AQP4 is also expressed in supportive 
cells in electrically excitable tissues where it could influence neurotransmission, 
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since AQP4 null mice present with a variety of disturbances such as: impaired 
hearing, vision, olfact and reduced seizure threshold. This fact is elegantly 
explained by the hypothesis of a K+ buffer role of supporting cells25. In this 
hypothesis, the supporting cells would regulate the extracellular compartment 
by controlling the amount of water and therefore the size of the extracellular 
space and the concentration of ions, like K+. In the absence of AQP4 the 
compartment would contract and slow the K+ re-uptake by the neighboring cells, 
therefore conditioning the excitability and conduction. 
 The experimental studies in mice also revealed unexpected participation of 
AQP’s in some physiologic phenomena: cell migration, cell proliferation, fat 
metabolism and skin hydration26. 
Regarding cell migration, AQP1 deletion in mice resulted in impaired growth 
and vascularity in implanted tumors. On the other hand, modification of cell lines 
that don’t normally express AQP resulted in increased migration when 
compared to the wild type. 
“Aquaporinopathies” are defined as human diseases caused by aquaporin 
dysfunction, the two mechanisms known until now are loss-of-function 
mutations and auto-immune response against extracellular epitopes on AQP4.  
Loss of function mutation are rare, but AQP2 mutation not-X-linked causes, 
as mentioned before, NDI, with an estimated incidence of 1in 20million births. 
The causative defect is an abnormal protein folding with retention in cytoplasm 
and plasma membrane targeting. The AQP0 thought of having an adhesion 
function in the lens fibers are the cause of some congenital cataracts due to 
AQP0 mutation. The association between AQP polymorphisms and disease and 
disease causing mutation of AQP’s has not been described27. 
The neuromyelitis optica (NMO) who shares some common traits with 
multiple sclerosis is a disease with ocular and spinal commitment characterized 
by blindness and paralysis. Hallmark of this pathology is the presence of IgG 
directed against AQP4. In fact these auto-antibodies when administered in rats 
with previous neuroinflammation, cause NMO symptoms. Currently, based on 
experience from oncology, with monoclonal antibody target therapeutics like 
trastuzumab, an NMO antibody is being developed to block the IgG-AQP428. 
AQP based diagnostics is still a undeveloped field, with much of the functional 
weight of polymorphisms not explored in depth and with the role of AQP’s in 
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other disease conditions not clear. The role of AQP’s in a specific disease 
needs to be clarified in order to be valuable in the clinical set. Exceptions are 
made for AQP based assay of serum antibodies in NMO, immunoreactive 
protein in urine to NDI and possible interest in AQP specific antibodies in skin 
and salivary glands immune diseases; AQP1 detection exams for proximal 
tubule injury. Parallel to this, the possibility of characterizing pathology 
specimens for AQP presence seems to be particularly promising in tumors, 
based on recent correlations of tumor grade and AQP expression29,30. 
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III- AQUAPORINS AND PERITONEAL DIALYSIS 
  
 The peritoneal membrane as a transport barrier 
 Impact of aquaporins in peritoneal exchange 
 Aquaporins and Ultrafiltration failure 
 Peritoneal Pathophysiology 
 Putative role of AQP’s in peritoneal fibrosis and inflammation 
 
Peritoneal dialysis together with hemodialysis represents the available renal 
replacement therapies for patients with end-stage renal disease (ESRD), 
defined by K/DOQI as a renal function with GFR inferior to 15mL/min/1,73m2.  
ESRD is a growing health problem with an estimated incidence of 2,786 million 
patients worldwide and with a 6.7% annual growth rate, in 2011. 
For its relative simplicity, lesser impact in the daylife of patients and lower 
costs in comparison to hemodialysis, PD is an attractive therapy31. The 
outcomes of both are considered equal, but PD presents an early survival 
advantage during the first years of therapy and to an extent it can be even 
greater depending on the burden of comorbidities.  
Peritoneal dialysis consists in using the peritoneal cavity and respective 
membrane as an interface of transport between circulating blood and a 
dialysate solution, in order to remove metabolites, toxins and water, therefore 
replacing kidney function. In practice this technique implies instillation of 
dialysate through a catheter, a resting period of hours and a final drainage. The 
manipulation of the system can be performed by the patient himself, referred as 
continuous ambulatory PD (CAPD) or by a mechanized device referred as 
automated PD (APD). 
The transport of solutes and water is obtained by the creation of a 
concentration and osmotic gradient through the membrane, with the use of 
dialysate with an osmotic agent (commonly glucose) and physiological 
concentrations of sodium, chloride, calcium, magnesium and a buffer to 
stabilize the pH. This way water is extracted by osmosis, small solutes by 
diffusion and macromolecules by convection (explored further ahead). 
The peritoneal cavity used in the procedure is of paramount importance but 
the concept of anatomical peritoneum and peritoneum as a transport barrier 
differs: the anatomical peritoneum is defined as the serosal lining of the 
abdominal cavity, the mesothelium32. The concept of transport barrier is far 
 18 
 
more complex, and includes the mesothelium, the interstitial matrix beneath it 
and the capillaries (Fig.2-A).  
Therefore the total anatomical surface area does not correspond to the 
functional surface area33 that compromises the peritoneum involved in the 
transport. The last depends on the arrangement of the capillaries in the 
interstitium: density, surface area and distribution, so that to a given surface 
area of peritoneum, only a portion will be in contact with the dialysate and of this 
portion only a fraction will meet the requirements to an effective transport.  
The mesothelium composed of a single layer of mesenchymal cells, with their 
own basement membrane and glycocalix, is responsible for lubrication of the 
serosa by secretion of phospholipids and glycosaminoglycans, preventing 
adhesions and has major pivotal role in host defenses. Nevertheless, it doesn’t 
represent a major barrier in transport, since no significant alteration was 
observed in the transfer rates in mice submitted to total peritonectomy and in 
patients with peritoneal carcinomatosis34. 
On the other hand, the interstitium is a matrix of amorphous substance of high 
molecular weight interlaced with bundles of fibres and cells (adipocytes, 
fibroblasts and occasionally monocytes), that contains also the arterial, venous 
and lymphatic vessels (mainly capillaries) and nerves. Since it constitutes the 
pathway between blood-dialysate, it is considered to be one of the two barriers 
of transport. The thickness and negative charge of the interstitium, are 
considered to account for the diffusion of both small solutes and 
macromolecules, since the thickness represents the length the solute most 
travel and a selection of macromolecules is made based on their charge 
(repulsion). 
The microvasculature is composed of true capillaries (Ø 5-6 µm) and 
postcapillary venules (Ø 7-20 µm). The capillaries are classified as continuous, 
with endothelial cells anchored to a basement membrane and closed together 
by adhesion junctional proteins. This layer is then encircled by a glycocalix. The 
endothelia besides is role in transport, actively secrets auto regulatory 
substances that control the tonicity of the vessels, like NO, EDHF and ET 
peptide family in addition to other promoters and growth inhibitors and other 
compounds involved in thrombogenesis, fibrinolysis and leukocyte adhesion. 
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The capillary wall of these vessels is considered the main barrier to exchange 
process and functionally has the behavior of an heteroporous structure 
composed of three pore sizes: large (200-400A), small (40-65 A), and ultrasmall 
(4-6A), demonstrated by Rippe et al35 as an accurate predictive model of 
transport. The pore size is intimately related to their selectivity and to forces that 
drive solutes through them (Fig.2-B): the large pore is permeable to 
macromolecules, small solutes and water where the predominant force is 
hydrostatic pressure; the small pores are permeable to small solutes and water 
and impermeable to solutes with molecular weight above 69.103 Da with 
hydrostatic and osmotic pressures as predominant forces33. The ultrasmall pore 
is a transcellular pore with osmotic pressure of low molecular weight solutes as 
drive force and permeability to water molecules only, later proven to be 
aquaporins (to be developed further ahead). The morphological equivalents to 
small pores are interendothelial clefts and large pores are believed to be larger 
than average interendothelial clefts (looser interendothelial adhesions). 
The transport in the barrier can therefore be divided in fluid transport and 
solute transport. Regarding fluid transport, it is considered tri-phasic: an initial 
net ultrafiltration with effective osmotic pressure on AQPs and passage of 
water; an isovolemic phase, with counterbalance of ultrafiltration through 
absorption and a final phase of net fluid absorption. 
Some factors influence the total amount of ultrafiltrated water, to be 
mentioned: the osmotic gradient start to decay as a result of the absorption of 
the osmotic agent, usually a small solute; a part of the water filtered into the 
peritoneal cavity is absorbed by influence of an elevated hydrostatic pressure 
into the lymphatic drainage, mainly stomata, a subset of lymphatic structures 
and into the adjacent tissues and also by backfiltration through the small pores. 
Paradoxically, under normal circumstances the blood flow rate is not a 
decisive variable as in other organs, but rather, as previously mentioned, the 
perfusion rate, the surface area of capillary available for transport (increased 
with vasodilation) and the recruitment of other microvessels. Recently, another 
factor was proposed by Stachowska-Pietka et al36, with results comparable to 
the actual model, in which spatial distribution of the capillaries also interferes 
with the exchanged based on the interaction of hydrostatic pressure and 
effective range of the osmotic pressure. As a result, not all capillaries are 
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involved in transport but only the closest to the peritoneum can be subject of the 
created gradients and participate in transport, resulting in a thin layer of 
effective vascular recruitment. 
Secondly, the solute transport is effectuated by solute diffusion according to 
the differences in concentrations between blood and dialysate (Fig.2), and by 
convection, the solute dragged with the water flux. Diffusion rate is proportional 
to the concentration gradient, the solute diffusion constant, and the effective 
surface area and inversely proportional to the diffusion distance. In clinical 
practice, knowing the volume flow and sieving coefficients, diffusion is easily 
calculated through the mass transport coefficients across the barrier (MTAC), 
based on initial and final concentration of solute in plasma and dialysate.  
 
Ultrafiltration and its product, free water, are very important in PD. 
Ultrafiltration is a predictive marker of survival, with a cumulative risk for 
permanent loss of UF after 1 year of 3% and after 6 years, of 31%, has reported 
by Heimbürger et al.37 As mentioned, the aquaporins are the morphological 
translation of the ultrasmall pores, and they are responsible for a high 
percentage of FWT in PD38.  
Cumulative data, from AQP1 null mice, began to demonstrate AQP1 as the 
ultrasmall pore, where Yang et al.39 registered a decrease in cumulative UF 
when exposed to a hypertonic solution. Further evidence was provided by Ni et 
al40, that demonstrated severe water transport dysfunction albeit appropriate 
osmotic charge. The 50% loss of UF was in line with the predicted AQP 
transport by the three pore model. Although not so dramatic, the mice with 
intermediate phenotype also presented impaired water transport. Previously, 
Carlsson et al.41 demonstrated the presence of AQP1 expression in the 
peritoneum and specific inhibition of 66% with HgCl2. 
These findings, corroborated some clinical observations of dissolution of 
sodium in dialysate during the first hour of dwell, creating a graphic dip in the 
sodium concentration latter attributed to the water transport through ultrasmall 
pores. This sodium dipping is now considered an indirect measure of UF. 
The inverse situation of increased expression and subsequent rise in UF was 
also demonstrated, this time Stoenoiu et al.42 based on the presence of 
glucocorticoid elements in the AQP promotor gene induced  an over expression 
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of AQP1 in mice with high doses of glucocorticoids with increased UF as result. 
Latter Arteaga et al.43 tried a similar approach in selected patients with 
promising results: an almost 2 fold increase in sodium dip and ultrasmall pore-
specific UF. 
In clinical practice, AQP function and contribution to UFF can be quantified by 
novel protocols of peritoneal transport. In practice, the patient is submitted to an 
individual assessment of his peritoneum transport characteristics and his 
transport profile is included in one of four distinct transport groups32 according 
to the obtained D/P creatinine: Fast transporter (above 1 SD); Faster than 
average transporter (between the mean and the superior SD); Slower than 
average (between the mean and the inferior SD) and Slow transporter (below -
1SD). The commun peritoneal equilibration test (PET) was standardized by 
Twardowski et al.44, and consists in a four hour dwell with a dialysate solution of 
2.27%/2.5% glucose, after a previous long dwell (8-12h). Samples of the 
effluent and dialysate bag are taken in the beginning and the 10, 30, 60, 120 
and 180 min. Serum samples are collected at the end. Measurements of solutes 
in samples are made, including: sodium, potassium, urea, glucose, creatinine 
and total proteins. The D/P ratios are calculated with the measured values. 
Other variations of PET were elaborated, worth mentioning: the fast PET, a 
simplified version of PET with only one sample per body fluid and measurement 
of only urea and creatinine; and the Mini-PET45, proposed by La Millia et al, that 
consists in 1 hour dwell with a 3.86/4.25% glucose  solution, assuming maximal 
free water transport with this osmotic gradient. Therefore it allows the 
calculation of FWT, a feature not present in standard PET and the possibility of 
distinguish net ultrafiltration changes due to small solutes or to FWT. In 2012, 
Bernardo et al46 proposed a different protocol based in the standard PET and 
mini-PET, in which an interim step was added to the sPET (total drainage at 60’ 
and weight of the ultrafiltrated water) which allows a more accurate and direct 
estimation of the NUF.   
Although AQP dysfunction can be a cause of UFF, UFF is a complex clinical 
situation with multifactorial causes and results in a functional fluid overload. 
UFF is defined by International Society of Peritoneal Dialysis as NUF inferior to 
400 mL after a 4h dwell with a glucose solution of a 3.86/4.25%. 
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 This can be attributed to high fluid intake, non-compliance, un-optimized 
prescription and low drained volume. The latest can be due to technical fault in 
the drainage system or peritoneal membrane failure. Peritoneal membrane 
failure includes several causative mechanisms to a low drained volume and 
according to patient transport status different causes can be suspected: in a 
slow transporter, disruption of the peritoneal space; in a fast transporter, 
inherently high transport, recent peritonitis and long term PD; finally in the 
intermediate transporter, technical fault, enhanced reabsorption and AQP 
deficiency. The pathophysiology will be addressed in more detail in the following 
section. 
 
Loss of peritoneal function is a dramatic outcome for patients in PD, since the 
treatment failure is up to 50% in patients with more than 6 years of therapy. 
Although this risk can be minimized with updated solutions and protocols.  
The use of peritoneum as dialytic membrane is an unnatural role for the living 
structure, and since the beginning of PD architectural alterations of the 
membrane can be found. The major causes of drop-out in long term PD are 
infections and the membrane failure, which in extreme cases can lead to a 
generalized peritoneal sclerosis and the establishment of encapsulating 
peritoneal sclerosis, herald of a poor prognosis47. 
This way peritoneal remodeling is a deleterious adaptation of the peritoneal 
membrane with structural and functional alterations in response to a variety of 
insults, acute (e.g. peritonitis) or chronic (e.g. PD itself). These induced 
alterations translate into modifications in the cell microenvironment and 
populations, with signaling pathways shifted towards inflammation, 
angiogenesis, remodeling (sclerosis) and recruiting of effector cells. 
As mentioned, since the first PD alterations in the membrane can be found, 
the mesothelium presents depopulated areas as a result of mesothelial cell 
loss, with punctual zones of high mesothelial density (i.e. regeneration process). 
Among these, vimentin positive cells, indicative of on-going endothelial to 
mesenchymal transformation, are present. The submesothelial layer shows 
progressively increased thickness, and infiltration by inflammatory cells. The 
increased thickness attenuates the effective osmotic pressure on capillaries. 
The angiogenesis and lymphangiogenesis results in an incremented number of 
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blood vessels that correlates with higher vascular area, faster absorption of 
glucose resulting in a decrease of osmotic pressure by early dissipation with a 
lower UF as final result. The lymphatic expansion produces enhanced 
reabsorption, further contributing to lower UF. Also, the loss of adhesion 
proteins induced by inflammation and remodeling results in larger vascular 
interendothelial gaps, with loss of proteins.  A shift in the imunne cell population 
is seen with predominance of neutrophils and in more chronic cases activated 
macrophages, with a higher than normal presence of milky spots (i.e. 
accumulation of macrophages). Animal studies show that in early PD, these 
alterations are a local phenomenon spread in clusters around the cavity, but 
with time and continuous stimulation, the lesions coalesce and become 
generalized. It is commonly accepted that the peritoneal remodeling resembles 
a chronic low-grade inflammation process. 
There are multiple causes that trigger peritoneal response and remodeling, 
such as the PD catheter, presence of PD solution in the cavity, the composition 
of the dialysate, uremia48 and peritonitis49. Their contribution and ability to 
trigger a response is variable among each other, but due their common 
presence in PD patients they are thought to act synergistically by activating the 
same signaling pathways. 
The PD catheter has been demonstrated to cause local response in the site 
of insertion; the PD solution causes physically induced stress in the 
mesothelium layer, with morphological alterations. Uremia in the other hand 
induces hyperemia and inflammation contributing to the overall vasculopathy. 
The composition of the dialysate causes inflammation via its lactacte, pH, and 
glucose content. The far most important aggressor is glucose and the products 
derived from it such as glucose degradation products (GDPs) and advanced 
glycation end-products (AGES) created during heat sterilization of solutions. 
GDPs and AGEs induce VEGF and TGF-β synthesis by MCs and they are 
considered the main mediators of peritoneal remodeling. Besides inducing 
oxidative cell stress50, the activation of AGE receptors (RAGE)51 is linked to 
activation of multiple signal-transduction pathways52, some of which involved in 
angiogenesis and fibrosis. The blockage or absence of these receptors results 
in significant reduction of EMT and fibrosis in mice models. 
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Peritonitis constitutes an acute event of massive inflammatory activity with 
release of multiple pro-inflammatory cytokines, with acute loss of UF, marked 
vascular proliferation and inflammatory infiltrates. Although the alterations are 
considered reversible53, sustained bacterial peritonitis can lead to irreversible 
loss of UF and permanent damage of the barrier. As demonstrated by Devuyst 
et al.54 in mice, the NOS plays an important part in the vascular changes during 
the event. Of the three isoforms present in the membrane – iNOS, eNOS and 
nNOS – the eNOS isoform controlled by intracellular Ca2+ levels, is responsible 
for the alterations in profile transport due to its vasoactive nature, with marked 
vasodilation, which allows greater absorption of glucose and dissipation of 
osmotic gradient, an enhanced infiltration of neutrophils and loss of proteins. 
The deletion of this isoform is accompanied by a reduction of these alterations. 
Despite the fact that the mesothelium is not a barrier for transport, it 
represents a keystone in peritoneal response to PD and infection, being 
responsible for the production cytokines and inflammatory mediators, in 
response to the mentioned external factors and to stimuli from other peritoneal 
cells. It is also capable of undergoing transdeferentiation, in an attempt to 
restore the loss of other mesothelial cells, in a process named endothelial-to-
mesenchymal transition (EMT)55,56. In this process, the cell starts to suffer a 
detachment of the underlying basement membrane, and it’s transformed into a 
fibroblast like cell with enhanced migratory and fibrogenic abilities55. This 
process is sustained by the presence of TGF-β57,58. In fact this growth factor is 
not only responsible for EMT, but also for the capability of mesothelial cells to 
activate myofibroblasts (i.e. fibrosis), vasculopathy59 and deposition of 
submesothelial layer60 since TGF-β induces MCs release of VEGF, FGF and 
other growth factors.  
The mesothelium repairing process is composed of three proposed 
mechanisms with still undefined weight of contribution, but thought to act in a 
complementary way: implementation of free mesothelial cells in suspension61; 
MCs at the border of denudated zones migrate to fill the gaps; and new MCs 
originate from the submesothelial layer and migrate to the damaged area. It 
worth mentioning that for this EMT ability, the mesothelium is considered a 
source of stem cells62 and it’s autologous transplantation is considered by some 
authors as an therapeutically option in PD63. 
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The RAAS system is recently being subject of investigation, based on the 
known effects of angiotensin in regulating cellular proliferation, apoptosis and 
fibrosis, with general profibrotic profile. Some tissues have the capability of 
producing all components of the RAAS axis, and this seems to apply to the 
peritoneum since MCs appear to have RAAS codifying genes has demonstrated 
by Nessim et al64. Glucose and the augmented hydraulic pressure induce 
activation of RAAS in MCs and subsequent production of angiotensin, with 
regulatory function in cell proliferation, apoptosis and fibrosis. These effects are 
achieved by the induction TGF-β / fibronectin production and ultimately of 
VEGF. This affects not also the vasculature with increased permeability, 
vasodilation and angiogenesis but also fibrosis. Recent attempts of using ACEi 
and ARB as a preventive measure against loss of UF, seem to have positive 
results: in rats, Duman et al.65 demonstrated preserved UF and significant 
decrease in VEGF levels when treated with a intraperitoneal dose of enalapril. 
Additionally, a retrospective study demonstrated maintenance in solute 
transport status in patients treated with oral ACEi/ARB. Pérez-Martinez et al.66 
recently demonstrated in mice, the benefits of aliskiren in UF preservation and 
protection of MCs against glucose oxidative stress with lesser proapoptotic 
molecules when compared to control. 
The complexity of peritoneal remodeling is also related to numerous activated 
signaling pathways. The conjunction of these result in the observed alterations 
in the peritoneum and an accelerated mesothelial cell cycle. So far the main 
pathways identified are COX2, p38MAPK, ROS, RAGE, JAK-STAT and 
Tyrosine Kinase Receptor pathway67,68.  
In fact, based on the current knowledge of peritoneal remodeling and the 
different transport profiles, it is suspected that individuals subject to PD have 
different levels of remodeling and baseline transport, not only due to pre-PD 
comorbidities but for the presence of polymorphisms in RAS, RAGE, VEGF, 
TGF-β which could result in an amplified response to PD. These are currently 
under investigation. 
Based in the current knowledge of AQPs, their importance is established in 
vascular endothelia and UF, as the hypothesized ultrasmall pore. But the recent 
advances in the field of aquaporins render more questions since they appear to 
be involved in innumerous physiological processes. Considering that the 
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mesothelium is subject to intense oxidative stress with ROS formation50 and 
exposure to GDPs, are the intracellular domains of aquaporins damaged and 
subsequently the pore conformation affected? It’s known that relation between 
pore geometry and water conductivity is critical, a single alteration can lead to 
drastic changes in water transport. Similarly other points of the aquaporin life 
cycle can be target of damage such as the folding as previously mentioned. 
Regarding the control of aquaporins in the cell, as highlighted before not all 
control mechanism are yet clarified, but based on the rapid translocation which 
uses intracellular calcium and PKC as effectors, can other pathways be 
involved in increased translocation? As calcium is a common second 
messenger69,70 to other pathways this may represent an opportunity for up-
regulation of translocation via “indirect” pathway.  
Also noteworthy is the fact that many signaling pathways are present in 
peritoneal remodeling but their final effect on the AQP status is not clear. Many 
signaling pathways translate into different intracellular mechanisms. Is there a 
prevalent pathway or the end-result is the conjunction of all stimuli? The answer 
might be related to MicroRNA. MicroRNA regulates mRNA expression by 
altering transcription and translation. They are small non-coding RNA 
molecules, well conserved in eukaryotic cells and one single miRNA can have 
multiple targets (mRNA). Altered expression was observed in some diseases. In 
other models of disease, microRNA 320a was presented as an endogenous 
modulator of AQP1 and AQP471-73 with possible interference in other cell 
processes, but the fact remains elusive.  
Also, given the ability of AQPs to alter the intracellular concentrations (by 
dilution), can they influence the cell function and intracellular pathways? 
AQP1 is present in vascular endothelia and in mesothelium. In the vascular 
endothelia, AQP up-regulation is considered beneficial since it contributes to a 
higher UF. On the other hand, Verkamn et al.74,75 reported impaired cell 
migration on AQP null mice. So, since AQP1 may also play a role in migration 
of inflammatory and mesothelial cells, up-regulation can translate into an 
enhanced pathological process. 
AQP might also influence apoptosis. As highlighted by some authors like 
Santamaria, Selgas, and Gotliob the mesothelium is subject of an accelerated 
life cycle, in which apoptosis controls the number of cells and their viability by 
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removal of undesirable cells and its control represents a therapeutic 
opportunity76-78. Apoptosis could be defined as a controlled cellular implosion 
with successive destruction of intracellular organelles, as a response to internal 
and external factors in which is included environmental stress79. Some authors 
postulate an involvement of AQPs in apoptosis, based in the diminished rate 
observed in AQP null cells. Recently Lee et al.80 hypothesized a role for AQP in 
mitochondrial fission after observation of impaired fission in presence of Hg2+. 
On the other hand Jablonsky et al.81 demonstrated Hg2+ based inhibition of 
AQP1 in blocking the apoptotic processes such as apoptotic cell volume 
decrease (AVD), DNA degradation and caspase3 activation in thymocytes and 
granulosa cells from the ovary. The overexpression of AQP1 resulted in 
enhanced apoptotic process. This volume depletion is proposed to facilitate the 
reduction of intracellular K+82,83 and the initiation of the apoptotic program. 
It seems that the apoptotic response involves a coordinate control of 
intracellular and membranar aquaporins, that together compose an axis of 
cellular volume control mediated by an unknown mechanism. 
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IV- AQUAPORINS AS THERAPEUTIC TARGETS 
  
 Antagonists 
 Agonists 
 Trends in Research 
 
Excluding the monoclonal antibody Anti-IgG AQP4, so far the compounds can 
be divided in antagonist and agonists.  
The pharmacological antagonists of AQP are transition metals (mercury, 
silver84, gold84), quaternary ammonium compounds85 (tetraethylammonium 
(TEA), sulfonamides and related compounds (acetazolamide)86 and phloretin87. 
The direct effect of these compounds is validated through residue site-directed 
mutagenesis: the suspected target of the inhibitor is altered via mutagenesis 
and substituted by another residue. In theory, the inhibitor loses his binding site 
and his ability to diminish water flow. If that’s the case the mutated residue is 
identified as a connection site of that compound. 
Transition metals, mercury in particular where the first known inhibitors 
followed by silver and gold but the role of these compounds is restricted to 
laboratory environment due to their high toxicity in vivo. Bearing in mind the 
similarities between AQPs and ion channels, it was at the time, suggested the 
ion channel blockers could also affect AQP. TEA, a pore-occluding K+ blocker, 
has antagonistic properties due to its interaction with the tyrosine 186 residue at 
outer vestibule, but in line with the transition metals, it effect in vivo has 
undesirable consequences since it blocks a variety of K+ channels, as such it is 
only used in an experimental basis. Phloretin is also mentionable for its dual 
inhibition profile, but unsuited for human blockage. 
Sulfonamides, a group that includes antiepilectic drugs is target of research, 
but with unconfirmed results in vivo. Also based on the low inhibition caused by 
bumetanide, a screening of chemical structure library was performed with 
bumetanide chemical structure as basis. This resulted in the discovery of 
AqB01388 that simultaneously blocks AQP1 and AQP4. 
The screening of the National Cancer Institute Small Molecule Collection with 
the novel fluorescence method result in 4 positive results: NSC164914, 
NSC670229, NSC168597 and NSC301460.Particularly interesting is the second 
molecule for its simple structure and reasonable inhibitory effect89. Recently, 
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three undisclosed compounds were considered inhibitors with no chemical 
similarity with the known compounds90. 
The existence of agonists is closely connected to gating, presuming a non-
maximal AQP conformation and possible optimization91. The theorized 
mechanism is the stablilization of the open conformation state of the pore by a 
ligand. The available ligand-sites proposed by docking simulations have been 
identified in the intra and extracellular domains92. 
So far the only therapeutic measure that in fact increased AQP action was 
based on an indirect mechanism, since AQP1 gene contains glucocorticoid 
response elements, Arteaga et al. demonstrated an increased in UF due to 
quantitative rise of aquaporins43. 
The modulation of aquaporins is an evolving subject but despite all the efforts 
currently undertaken some obstacles such as the lack of natural endogenous 
ligands and the poor adequacy of heavy metal based assays to detect small 
organic compounds  need to be surpassed in order to accelerate the drug 
discovery process. Great amount of information about possible binding sites 
and effectiveness is being given by computer modulation of AQPs and it 
represents a valuable source of information.  
 The advances in the automated cell assay93 provided the capability of even 
faster and higher output and the screening of library compounds with effective 
results. Although better, it still doesn’t reflect the complexity of intracellular 
mechanisms and the possibility of indirect modulation; new models and greater 
knowledge of the AQPs “life cycle” are needed in order to accommodate these 
possibilities. The recent advances in AQP function as a cationic channel94 may 
also give rise to other therapeutic classes once its importance and role in 
pathophysiology is established.  
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V- CONCLUSIONS 
 
Peritoneal dialysis represents a viable and attractive form of renal 
replacement. It is clear that the solution for a more effective and long-lasting 
technique are more biocompatible solutions and remodeling blockers. This is 
only possible with greater insight of the peritoneal pathophysiology. 
AQP represents the ultrasmall pore and is responsible for the UF and FWT 
observed in PD. In clinical practice the quantification of AQP function, UF 
translates into a deepest and more knowledge about patient transport profile. 
Other roles for aquaporins in the pathophysiology of the peritoneal barrier are 
currently under investigation, but without a doubt they are a part of the observed 
alterations and pathological processes. Their study will bring further knowledge 
relevant not only to PD, but to human physiology and cell biology. 
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